For Low Risk Prostate Cancer, Personalized Monitoring An Option
Active surveillance may be a viable option for some men with prostate cancer. Regular tests and careful tracking of any changes in the patient’s disease risk over time are imperative to ensure good outcomes, according to researchers in Toronto presenting at the annual meeting of the American Urological Association (AUA).
Miami Team Finds Most Low-Risk Patients Stay Treatment-Free for Five Years
For men diagnosed with low-risk prostate cancer, active surveillance can be a sensible first step in managing the disease. Mark Solloway and a team of urologists at University of Miami Miller School of Medicine have reported on outcomes for a group of their patients.
For Slow Growing Prostate Cancer Delay May be Reasonable, Hopkins Study Finds
Delaying surgery — even for years — for patients with small, low-grade prostate cancer does not appear to increase the risk of the disease progressing to an incurable form, according to a 10-year Johns Hopkins Medicine study. This discovery could prevent over-treatment, the authors say.